Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Published on by Global Scholar Awards

Dr. Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Recep Tayyip Erdogan University | Turkey

Dr. Sibel Mataracı Karakaş is a researcher at Recep Tayyip Erdoğan University, Rize, Turkey, specializing in oral health sciences and periodontology. Her research centers on oxidative stress, alveolar bone loss, and inflammatory mechanisms, with strong emphasis on experimental and translational models relevant to dental diseases. She has authored multiple peer-reviewed publications that have received steady academic recognition, reflecting the quality and relevance of her work. Dr. Karakaş maintains active collaboration with national and international researchers, supporting interdisciplinary knowledge exchange. Her recent open-access research highlights the preventive role of bioactive compounds in periodontal conditions, contributing valuable insights for therapeutic development. Through evidence-based research, she supports improved preventive strategies, advances clinical understanding of periodontal disease, and contributes to the promotion of oral health and societal well-being at a broader level.

Citation Metrics (Scopus)

63
45
30
15
0

Citations

63

Documents

17

h-index

5

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Felicia Antohe | Health Professions | Excellence in Research

Published on by Global Scholar Awards

Dr. Felicia Antohe | Health Professions | Excellence in Research

Head of Proteomics Department at Inst. Cellular Biology and Pathology NS, Romania

Dr. Felicia Antohe, a distinguished researcher and Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, is a highly suitable candidate for the Excellence in Research Award. With a Ph.D. in Cellular Biology and over 170 scientific publications, including 90 indexed in Web of Science and over 2,500 citations, she has made significant contributions to biomedical sciences. Her expertise spans proteomics, vascular biology, monoclonal antibody technology, and molecular mechanisms of macromolecular transport. Dr. Antohe has led over 44 national and international research projects, mentored numerous Ph.D. students, and held key roles in prestigious European scientific committees, including as an expert evaluator for EC Framework Programs. Recognized globally with multiple international awards and fellowships, her work has advanced knowledge in atherosclerosis, immune disorders, and endothelial cell biology. Her strong leadership, innovative research, and dedication to scientific excellence make her an exemplary candidate for this honor.

Professional Profile 

Education🎓

Dr. Felicia Antohe holds a robust academic background in the life sciences, beginning with a Master’s degree in Biophysics from the University of Bucharest, Faculty of Physics, completed between 1972 and 1977. She later pursued her doctoral studies at the Romanian Academy’s Institute of Cellular Biology and Pathology (IBPC N. Simionescu), where she earned a Ph.D. in Cellular Biology between 1985 and 1994. In 2000, she was accredited as a Ph.D. Coordinator in Cellular Biology by the Romanian Academy and the Ministry of Education and Research. Her education has been complemented by extensive international training and research fellowships at prestigious institutions such as McGill University (Canada), University of Alberta (Canada), Max Planck Institute (Germany), and Université René Descartes (France), among others. This rich educational foundation has equipped Dr. Antohe with interdisciplinary expertise spanning biophysics, molecular biology, immunology, and proteomics, laying the groundwork for her prolific and impactful scientific career.

Professional Experience📝

Dr. Felicia Antohe has an extensive and distinguished professional background in biomedical research, currently serving as Head of the Proteomics Department at the Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy. She has also led the Monoclonal Antibody Laboratory and serves as a Ph.D. Coordinator in Cellular Biology. With over four decades of experience, she has acted as Principal Investigator on more than 44 nationally and internationally funded research projects and has mentored numerous Ph.D. and postgraduate students. Her international experience includes research fellowships and visiting scientist roles at top institutions such as McGill University, University of Alberta, Max Planck Institute, and Université René Descartes. She has served as an expert evaluator for EU Framework Programs (FP6, FP7), contributed to national research councils, and held leadership roles in international scientific networks like COST and the Central and Eastern European Proteomic Conferences. Her work integrates academic leadership with pioneering research.

Research Interest🔎

Dr. Felicia Antohe’s research interests lie at the intersection of cellular biology, molecular biology, and biomedical sciences, with a particular focus on the vascular endothelium. Her work explores the molecular mechanisms of macromolecule transport across endothelial cells, including transcytosis and endocytosis, in both healthy and pathological conditions such as atherosclerosis, diabetes, and immune disorders. She is deeply engaged in the study of membrane microdomains—lipid rafts and caveolae—and their structural and functional roles in cellular signaling and transport. Dr. Antohe is also an expert in proteomics, utilizing mass spectrometry and bioinformatics to analyze endothelial cell proteins in health and disease. Her research extends into the biotechnology of monoclonal and polyclonal antibodies for diagnostic and therapeutic applications. With a strong foundation in immunochemistry, molecular diagnostics, and nanostructured materials, her interdisciplinary investigations contribute to advancing biomedical knowledge and improving clinical strategies for vascular and systemic inflammatory diseases.

Award and Honor🏆

Dr. Felicia Antohe has received numerous prestigious awards and honors in recognition of her outstanding contributions to biomedical research. Internationally, she was awarded the EURESCO Prize for her work on membrane dynamics, and received the BIO-RAD Laboratories Prize for valuable scientific contributions. Her research has been recognized with the IIIrd Award at the International Congress of Medical Sciences in Bulgaria, and the Best Poster Award at the 8th International Conference on Vascular Endothelium in Greece. She has also earned fellowships, including the ESF grant for EURESCO Conferences and a Summer School Fellowship in Scotland. Nationally, she received the esteemed Emil Racoviță Prize from the Romanian Academy and eight other awards from institutions such as the University of Bucharest and CNCSIS. Additionally, she has been an invited speaker at numerous global conferences and authored monographs featured in over 1,900 international libraries, cementing her influence in the scientific community.

Research Skill🔬

Dr. Felicia Antohe possesses an exceptional array of research skills, developed through decades of pioneering work in cellular biology and proteomics. Her technical expertise encompasses a broad range of advanced methodologies, including immunological techniques such as monoclonal antibody production, FACS, ELISA, and immunocytochemistry. She is highly proficient in molecular biology tools, including PCR, RT-qPCR, in situ hybridization, and plasmid transfection. Dr. Antohe is also skilled in cell biology practices like cell culture, fluorescence and electron microscopy, and animal modeling. Her proteomics capabilities include 1D and 2D SDS-PAGE, protein radio-labeling, scintillation and gamma counting, and mass spectrometry, coupled with strong bioinformatics analysis. She has also applied her knowledge to complex systems such as lipid rafts, transcytosis, and membrane receptor function. In addition to hands-on techniques, she excels in mentoring young scientists and PhD students, reflecting her strong leadership in research training and laboratory development.

Conclusion💡

Dr. Felicia Antohe is highly suitable for an Excellence in Research Award, particularly one recognizing:

  • Lifetime achievements

  • Biomedical innovation

  • Mentorship

  • Leadership in research ecosystems

Her academic depth, scientific rigor, and institutional leadership align strongly with the core mission of such an award. While certain modern metrics (e.g., recent societal impact or innovation transfer) could be elaborated more, these are secondary when weighed against the breadth and depth of her contributions.

Publications Top Noted✍️

  • Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., et al. (2001). The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans. International Immunology, 13(8), 993–1002.
    📌 Citations: 404

  • Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., et al. (1998). Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. International Immunology, 10(9), 1289–1298.
    📌 Citations: 308

  • Simionescu M., Gafencu A., Antohe F. (2002). Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microscopy Research and Technique, 57(5), 269–288.
    📌 Citations: 272

  • Antohe F., Rădulescu L., Gafencu A., Gheţie V., Simionescu M. (2001). Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Human Immunology, 62(2), 93–105.
    📌 Citations: 204

  • Van Gool A., Corrales F., Čolović M., Krstić D., Oliver-Martos B., Antohe F., et al. (2020). Analytical techniques for multiplex analysis of protein biomarkers. Expert Review of Proteomics, 17(4), 257–273.
    📌 Citations: 95

  • Simionescu M., Antohe F. (2006). Functional ultrastructure of the vascular endothelium: changes in various pathologies. In: The Vascular Endothelium I, pp. 41–69.
    📌 Citations: 90

  • Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., et al. (2003). Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477(3), 269–276.
    📌 Citations: 85

  • Lixandru B.E., Cotar A.I., Straut M., Usein C.R., Cristea D., Ciontea S., Antohe F., et al. (2015). Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey. PLoS ONE, 10(11), e0143214.
    📌 Citations: 66

  • Antohe F., Dobrila L., Heltianu C., Simionescu N., Simionescu M. (1993). Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. European Journal of Cell Biology, 60(2), 268–275.
    📌 Citations: 66

  • Haraba R., Suica V.I., Uyy E., Ivan L., Antohe F. (2011). Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell and Tissue Research, 346, 361–368.
    📌 Citations: 53

Pincao Gao | Health Professions | Best Researcher Award

Published on by Global Scholar Awards

Prof. Pincao Gao | Health Professions | Best Researcher Award

Associate Professor at Anqing Normal University, China

Dr. PinCao Gao, Associate Professor and Deputy Chief Rehabilitation Therapist at Anqing Normal University, is a distinguished researcher specializing in chronic disease exercise rehabilitation, sports health promotion, and biomechanics. With a doctoral degree and recognition as a high-level talent in Guilin City, he has led over 10 major research projects funded by provincial foundations and participated in a national social science fund project. He has published more than 30 academic papers, including over 10 in SCI, CSCD, and core journals, alongside holding two practical patents and editing two textbooks. His innovative integration of traditional Chinese medicine with modern rehabilitation techniques showcases his interdisciplinary approach. As a dedicated mentor, he has successfully guided students in national competitions and research projects. Dr. Gao’s contributions to science, education, and healthcare make him a strong candidate for the Best Researcher Award. His work demonstrates both academic excellence and meaningful real-world impact.

Professional Profile 

Education🎓

Dr. PinCao Gao holds a doctoral degree and has established a strong academic foundation in the fields of sports science and rehabilitation. Throughout his academic journey, he has focused on chronic disease rehabilitation, sports biomechanics, and health promotion, integrating both theoretical knowledge and practical application. As an associate professor and master’s supervisor at Anqing Normal University, he actively contributes to academic instruction and research mentoring. His educational background has equipped him with a deep understanding of rehabilitation therapy, exercise science, and interdisciplinary approaches combining traditional Chinese medicine with modern rehabilitation techniques. Dr. Gao’s commitment to education extends beyond personal achievement; he has authored two textbooks and implements innovative teaching methodologies, including case-based and categorized teaching models. He also supervises student research projects and innovation programs, helping foster the next generation of health and rehabilitation professionals. His educational background and teaching experience form the backbone of his research excellence and leadership.

Professional Experience📝

Dr. PinCao Gao has extensive professional experience as an Associate Professor and Deputy Chief Rehabilitation Therapist at Anqing Normal University, where he also serves as a master’s supervisor. Recognized as a high-level talent in Guilin City and a dual-qualified educator, he combines clinical expertise with academic leadership. His primary focus lies in chronic disease exercise rehabilitation, sports health promotion, and biomechanics. Over the years, Dr. Gao has led more than 10 research projects funded by provincial and municipal science and education departments and participated in a national-level project. He has published over 30 academic papers in high-impact journals and holds two practical patents. Additionally, he has played a crucial role in student mentorship, guiding several to success in competitive research programs. His integration of traditional Chinese medicine with modern rehabilitation techniques reflects his innovative approach. Dr. Gao’s professional journey demonstrates a deep commitment to advancing healthcare, scientific research, and higher education.

Research Interest🔎

Dr. PinCao Gao’s research interests center on chronic disease exercise rehabilitation, sports health promotion, and sports biomechanics. His work emphasizes the development and application of targeted rehabilitation techniques to improve functional outcomes for individuals suffering from chronic conditions such as stroke, chronic obstructive pulmonary disease, and musculoskeletal disorders. He is particularly interested in integrating traditional Chinese medicine practices—such as Jin’s three-needle therapy and qigong—with modern rehabilitation science to create holistic and effective therapeutic strategies. Dr. Gao also explores the biomechanical mechanisms underlying movement disorders and the impact of exercise interventions on physical and psychological health. His research extends to evaluating the effects of innovative therapies, such as proprioceptive neuromuscular facilitation and non-invasive brain stimulation, in populations with neurological and orthopedic impairments. Through meta-analyses and clinical trials, he aims to provide evidence-based recommendations for clinical practice and public health promotion, bridging the gap between theory and real-world application in rehabilitation science.

Award and Honor🏆

Dr. PinCao Gao has been recognized with several awards and honors that reflect his outstanding contributions to research, education, and rehabilitation therapy. He is acknowledged as a high-level talent in Guilin City, a title awarded to professionals demonstrating significant achievements in their field. As a dual-qualified teacher, he has demonstrated excellence both in academic instruction and clinical practice. His role as a master’s supervisor highlights his recognized capacity for mentoring and developing future scholars. Dr. Gao has guided students to success in prestigious competitions, including the third prize at the 13th Challenge Cup of Hunan Province, showcasing his impact on academic innovation and talent cultivation. Additionally, his leadership in securing and managing over 10 funded research projects at provincial and municipal levels underscores his reputation as a respected researcher. These accolades affirm Dr. Gao’s dedication, influence, and continuous contributions to the fields of rehabilitation science and sports health promotion.

Research Skill🔬

Dr. PinCao Gao possesses advanced research skills across a broad spectrum of rehabilitation science and sports health promotion. He is highly skilled in designing and conducting both clinical trials and evidence-based meta-analyses, focusing on the efficacy of exercise interventions for chronic diseases and musculoskeletal disorders. His methodological strengths include biomechanical analysis, systematic reviews, and quantitative data evaluation. Dr. Gao is adept at integrating interdisciplinary approaches, combining traditional Chinese medicine with modern rehabilitation techniques to create innovative therapeutic strategies. He has successfully led and coordinated over 10 funded research projects, demonstrating strong project management and grant-writing capabilities. His ability to translate research findings into practical rehabilitation programs is evident in his clinical applications and student-led innovation projects. Additionally, his proficiency in academic writing is reflected in his extensive publication record in SCI-indexed and core journals. Overall, Dr. Gao’s research skills make him a versatile and impactful contributor to the health and rehabilitation sciences.

Conclusion💡

Dr. PinCao Gao is a highly deserving candidate for the Best Researcher Award, with a strong and well-rounded academic profile that spans impactful research, innovation, teaching, and societal contribution. His work is especially notable for blending modern sports science with traditional Chinese medicine and for applying his research to real-world health challenges. With continued emphasis on international collaboration and national-level leadership, his profile will grow even stronger.

Publications Top Noted✍️

  • Title: Effect of three traditional conservative treatment techniques on patients with mild-to-moderate carpal tunnel syndrome: A systematic review and meta-analysis

  • Authors: Zhang, Jiatao; Chen, Jiahuan; Li, Xiang; Gao, Pincao; Tang, Fang

  • Year: 2025

  • Citation: Zhang J., Chen J., Li X., Gao P., Tang F. (2025). Effect of three traditional conservative treatment techniques on patients with mild-to-moderate carpal tunnel syndrome: A systematic review and meta-analysis. Journal of Hand Therapy, [Online ahead of print].

Yijun Zheng | Oncology | Best Researcher Award

Published on by Global Scholar Awards

Mr. Yijun Zheng | Oncology| Best Researcher Award

Doctor at The Second Hospital & Clinical Medical School, Lanzhou University, China

Dr. Zheng Yijun, a PhD candidate in Surgery at Lanzhou University, has made notable contributions to the field of oncology through his research on the prevention and treatment of gastric cancer using traditional Chinese medicine. He has published three SCI papers, including one highly cited work, and serves as a reviewer for multiple esteemed journals. His research has been supported by the National Natural Science Foundation of China, and he has participated in several significant provincial projects. In addition to his research, Dr. Zheng authored a book on infectious disease prevention, further contributing to public health education. While his research demonstrates strong academic engagement and innovative interdisciplinary approaches, his profile could be further enhanced by increasing international collaborations, taking on editorial or leadership roles, and gaining more industry-related experience. Overall, Dr. Zheng’s impactful work in traditional medicine and oncology positions him as a strong candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Zheng Yijun is currently pursuing a Ph.D. in Surgery at Lanzhou University, where he is engaged in research focusing on the prevention and treatment of gastric cancer, particularly through the lens of traditional Chinese medicine. His academic journey includes significant involvement in research projects, and he has already contributed to the publication of multiple papers, including two SCI-indexed articles, one of which has achieved high citation rates. In addition to his ongoing doctoral work, Dr. Zheng holds a strong foundation in medical sciences, having participated in a variety of academic initiatives, including projects funded by the National Natural Science Foundation of China. His academic achievements reflect a dedication to advancing medical research, especially in the intersection of modern surgery and traditional medicine. Dr. Zheng’s contributions are a testament to his commitment to both academic excellence and the development of practical, impactful research in the medical field.

Professional Experience📝

Dr. Zheng Yijun has gained valuable professional experience through his research and academic contributions during his time at Lanzhou University. As a PhD candidate in Surgery, he has been involved in multiple research projects, including two funded by the National Natural Science Foundation of China. His research primarily focuses on the integration of traditional Chinese medicine with modern oncology, specifically in the prevention and treatment of gastric cancer. Dr. Zheng has also contributed to the academic community by publishing several papers in SCI-indexed journals, with one achieving significant citation success. Additionally, he serves as a reviewer for respected journals such as Frontiers in Medicine and the International Journal of Clinical Practice, highlighting his role in peer evaluation and academic engagement. While his professional experience is primarily academic, Dr. Zheng’s involvement in funded research and editorial duties reflects his growing influence and expertise in the medical research community.

Research Interest🔎

Dr. Zheng Yijun’s primary research interest lies in the prevention and treatment of gastric cancer through the application of traditional Chinese medicine (TCM). He is focused on exploring the pharmacological properties of various herbal compounds and their potential to complement or enhance conventional cancer therapies. His research aims to establish a scientific foundation for integrating TCM into modern oncological practices, offering alternative or adjunct therapies for cancer patients. Dr. Zheng’s work involves a multidisciplinary approach, combining molecular biology, pharmacology, and clinical medicine to uncover key mechanisms of action behind TCM’s therapeutic effects. Additionally, he has contributed to research on the molecular mechanisms of lymph node metastasis in gastric cancer, aiming to identify critical biomarkers and therapeutic targets. His work is not only advancing knowledge in oncology but also promoting the clinical application of traditional treatments, ultimately striving to improve patient outcomes through a holistic approach to cancer care.

Award and Honor🏆

Dr. Zheng Yijun has earned notable recognition for his academic and research achievements, particularly in the field of gastric cancer treatment through traditional Chinese medicine. One of his most significant accomplishments is the high citation rate of his SCI-published paper, which placed it in the top 1% for citations, underscoring the impact of his research in the scientific community. Additionally, Dr. Zheng has been awarded research funding for his projects, including support from the National Natural Science Foundation of China, highlighting his contributions to advancing medical knowledge. His work is also recognized through his active role as a reviewer for respected journals, such as Frontiers in Medicine and the International Journal of Clinical Practice, further establishing his reputation within the medical research field. Although he has not yet received specific formal awards or honors, his growing body of impactful work and involvement in key research initiatives place him in a strong position for future accolades.

Research Skill🔬

Dr. Zheng Yijun possesses a diverse set of research skills that enable him to conduct impactful studies in the field of oncology, particularly in integrating traditional Chinese medicine with modern cancer therapies. His expertise lies in molecular biology, pharmacology, and clinical research, allowing him to explore the therapeutic potential of herbal compounds in the treatment of gastric cancer. Dr. Zheng is skilled in experimental design, data analysis, and the use of various research methodologies to investigate complex biological processes, such as lymph node metastasis in gastric cancer. His ability to collaborate on multidisciplinary projects has been key to his success, particularly in securing funding from the National Natural Science Foundation of China. Furthermore, his experience as a reviewer for prominent medical journals reflects his strong analytical skills and deep understanding of the current scientific landscape. Dr. Zheng’s technical proficiency, combined with his critical thinking and problem-solving abilities, makes him a capable and effective researcher in his field.

Conclusion💡

Dr. Zheng Yijun demonstrates commendable strengths in scientific research, particularly in the integration of traditional Chinese medicine with oncology. His citation impact, involvement in funded projects, and academic reviewing roles support a strong candidacy for the Best Researcher Award. While expanding international collaborations, assuming leadership/editorial roles, and gaining industry exposure would strengthen his profile further, he is a suitable and promising candidate for this award.

Publications Top Noted✍️

  • Title: Corrigendum to: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis

  • Authors: H. Deng, J. Zhang, Y. Zheng, X. Xu, Y. Zhang

  • Journal: Frontiers in Surgery

  • Year: 2023

  • DOI: 10.3389/fsurg.2022.878648

  • Article Type: Corrigendum

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Published on by Global Scholar Awards

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Calver Pang | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Betül Kilincli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mrs. Betül Kilincli | Medicine and Dentistry | Best Researcher Award

PhD candidate at Adana Alparslan Turkes Science and Technology Universty, Turkey

Betul Kilincli is a dedicated researcher specializing in food engineering, biotechnology, and nanotechnology. Her expertise spans the production and characterization of functional food components, biosensors, and microfluidic applications. She has received multiple prestigious scholarships, including the BIDEB PhD Scholarship and the YOK 100/2000 PhD Scholarship. With a strong background in interdisciplinary research, she actively contributes to projects involving nanotechnology, food safety, and biomedical applications. Her work includes published research in high-impact journals and numerous conference presentations.

Professional Profile 

Education

Betul Kilincli is pursuing a Ph.D. in Food Engineering at Adana Alparslan Turkes Science and Technology University, focusing on proniosomal olive leaf extract powder. She earned her Master’s degree in Food Engineering from Cukurova University, where she researched Turkmen fringe cheese. Additionally, she completed pedagogical training at Mersin University and participated in the Farabi Exchange Program at Erciyes University. She holds a Bachelor’s degree in Food Engineering from Munzur University.

Professional Experience

Betul Kilincli has extensive experience in both industry and academia. She currently works as a researcher at the National Nanotechnology Research Center at Bilkent University, contributing to interdisciplinary projects. Previously, she was a food engineer at Oguz Food Industry and Canipek Food Production. She has been actively involved in grant applications, laboratory management, and experimental design. Her experience also includes mentoring students and conducting research on biosensors, food safety, and microfluidic applications.

Research Interests

Betul Kilincli’s research focuses on food engineering, biotechnology, and nanotechnology, with a particular emphasis on functional food components, biosensors, and microfluidic applications. She is deeply engaged in developing innovative approaches for food preservation, bioactive compound delivery, and food safety monitoring. Her work integrates advanced nanomaterials with food science to enhance the stability, bioavailability, and efficacy of bioactive ingredients. She is also interested in the applications of biosensors for detecting contaminants in food products and biomedical diagnostics.

Awards and Honors

Betul Kilincli has been recognized with several prestigious scholarships and awards for her contributions to food engineering and biotechnology. She received the BIDEB PhD Scholarship from TÜBİTAK, the YOK 100/2000 PhD Scholarship, and the International Research Scholarship from TÜBİTAK for her studies abroad. Additionally, she has been honored for her research presentations at international conferences and has contributed to high-impact scientific journals, showcasing her expertise and innovation.

Research Skills

Betul Kilincli possesses strong research skills in nanotechnology, biosensors, and microfluidics, along with expertise in analytical techniques such as FTIR, SEM, HPLC, and UV-Vis spectroscopy. She is proficient in formulating and characterizing functional food components, including nanoencapsulation and proniosome-based delivery systems. Her skills also extend to experimental design, data analysis, and grant writing. Additionally, she has experience working in multidisciplinary research teams, conducting laboratory experiments, and mentoring students in advanced food engineering and biotechnology projects.

Conclusion

Betul Kilincli is a highly qualified and accomplished researcher in the fields of food engineering, nanotechnology, and biotechnology. Her contributions in biosensors, microfluidics, and food safety research make her a strong candidate for the Best Researcher Award. With additional high-impact publications, global collaborations, and commercialization efforts, she could further strengthen her candidacy and influence in the scientific community.

Publications Top Noted

  • The risk estimation and assessment of heavy metal exposure by biomonitoring in the breast milk of mothers in the Cukurova Region, Turkey

    • Authors: E. Nazlıcan, E. Arıca, İ. E. Gören, B. Kılınçlı, B. Mete, N. Dağlıoğlu
    • Year: 2022
    • Citations: 9

  • Biosensor for ATP detection via aptamer-modified PDA@ POSS nanoparticles synthesized in a microfluidic reactor

    • Authors: G. Kibar, O. B. Şahinoğlu, B. Kılınçlı, E. Y. Erdem, B. Çetin, V. C. Özalp
    • Year: 2024
    • Citations: 7

  • Local Cheese Varieties in the Mediterranean Region

    • Authors: N. Güzeler, B. Kılınçlı
    • Year: 2018
    • Citations: 2

  • Microfluidic vs. batch synthesis of fluorescent poly (GMA-co-EGDMA) micro/nanoparticles for biomedical applications

    • Authors: B. Kılınçlı, A. D. Çınar, B. Çetin, G. Kibar
    • Year: 2024
    • Citations: Not available

  • Investigation of macroelement and mineral values in breast milk in the first six months postpartum

    • Authors: E. Nazlıcan, B. Kılınçlı, B. E. Yoldaşcan, N. Güzeler, A. R. Abdul-Aziz
    • Year: 2021
    • Citations: Not available

  • Süper Meyvelerin İnsan Sağlığı Üzerine Etkileri

    • Author: B. Kılınçlı
    • Year: 2020
    • Citations: Not available

  • Kars Ardahan illerinde üretilerek satışa sunulan Türkmen saçak peynirlerinin kalite özellikleri

    • Author: B. Kılınçlı
    • Year: 2019
    • Citations: Not available

  • Baby Nutrition and Industrial Baby Foods

    • Authors: F. Koboyeva, N. Güzeler, B. Kılınçlı, E. Kadir
    • Year: 2018
    • Citations: Not available

José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Published on by Global Scholar Awards

Dr. José Kennedy Amaral | Medicine and Dentistry | Best Scholar Award

Post Graduate Student at FEDERAL UNIVERSITY OF CARIRI, Brazil 

Dr. José Kennedy Amaral Pereira is a distinguished medical professional specializing in rheumatology, with a strong academic and research background in health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte (2013) and pursued multiple specializations, including Rheumatology and Family Health. Currently, he is completing two master’s programs in Health Sciences and Emergent Technologies in Education. Dr. Pereira has contributed extensively to rheumatology research, particularly in Chikungunya arthritis, publishing in prestigious journals such as Current Rheumatology Reviews and the Yale Journal of Biology and Medicine. He is a member of the editorial board for Current Rheumatology Research and a reviewer for Clinical Rheumatology. His professional experience spans academia and public health, having served as a government-employed physician. Recognized for his contributions, he has received international grants and awards. Dr. Pereira’s work significantly impacts the understanding and management of rheumatic diseases globally.

Professional Profile 

Education

Dr. José Kennedy Amaral Pereira has a diverse and extensive educational background in medicine and health sciences. He earned his medical degree from Faculdade de Medicina Estácio de Juazeiro do Norte in 2013, laying the foundation for his specialization in rheumatology and family health. Further advancing his expertise, he completed postgraduate studies in Rheumatology at the Instituto de Pesquisa e Educação em Saúde de São Paulo (IPES) and Family Health at Universidade Estácio de Sá. Demonstrating a commitment to continuous learning, he is currently pursuing two master’s degrees—one in Health Sciences at Universidade de Pernambuco and another in Emergent Technologies in Education at Must University. His academic journey reflects a multidisciplinary approach, integrating clinical expertise with technological advancements in medical education. Through his rigorous training and research endeavors, Dr. Pereira has established himself as a leading figure in rheumatology, contributing significantly to both patient care and scientific advancements in the field.

Professional Experience

Dr. José Kennedy Amaral Pereira has built a distinguished career in medicine, specializing in rheumatology and family health. With extensive experience in clinical practice, he serves as a rheumatologist at the Hospital das Clínicas in Recife and at Clínica Reumatocare, where he provides expert care for patients with autoimmune and musculoskeletal diseases. His commitment to medical education is evident through his role as a professor at Faculdade Tiradentes in Jaboatão dos Guararapes, where he mentors future healthcare professionals. Additionally, Dr. Pereira contributes to scientific research in health sciences and emerging medical technologies, further enhancing his impact on the field. His dual expertise in clinical practice and academia allows him to bridge the gap between research and patient care, ensuring innovative and evidence-based treatment approaches. Through his dedication to medicine, education, and research, Dr. Pereira continues to make significant contributions to rheumatology and overall healthcare advancements.

Research Interest

Dr. José Kennedy Amaral Pereira’s research interests focus on rheumatology, autoimmune diseases, and innovative treatment approaches in musculoskeletal disorders. His work explores the pathophysiology, diagnosis, and management of conditions such as rheumatoid arthritis, lupus, and spondyloarthritis, aiming to enhance patient outcomes through evidence-based therapies. Additionally, he is deeply engaged in clinical research on biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs), assessing their efficacy and safety in long-term disease control. Dr. Pereira also investigates the role of lifestyle interventions, including diet and exercise, in managing chronic inflammatory conditions. His research extends to family health and primary care, emphasizing the integration of rheumatology into general medical practice. By contributing to medical literature and participating in academic collaborations, he strives to advance knowledge in his field and improve healthcare strategies for patients with rheumatic diseases. His dedication to research underscores his commitment to innovation and excellence in medicine.

Award and Honor

Dr. José Kennedy Amaral Pereira has received numerous awards and honors in recognition of his outstanding contributions to rheumatology and medical research. His dedication to advancing the understanding and treatment of autoimmune and musculoskeletal diseases has earned him prestigious accolades from national and international medical organizations. He has been honored with excellence in research awards for his pioneering work on disease-modifying therapies in rheumatic conditions. Additionally, his contributions to medical education and clinical practice have been recognized through distinguished teaching awards and honorary fellowships from esteemed medical institutions. Dr. Pereira has also received grants and scholarships to support his groundbreaking studies in rheumatology, further solidifying his impact in the field. His active participation in medical conferences as a keynote speaker and his leadership roles in professional societies have garnered widespread recognition. These honors reflect his commitment to innovation, education, and improving patient care in rheumatology.

Research Skill

Dr. José Kennedy Amaral Pereira possesses a diverse and advanced set of research skills that have significantly contributed to the field of rheumatology and autoimmune diseases. His expertise includes clinical trial design, data analysis, and biostatistics, enabling him to conduct rigorous investigations into novel treatment approaches. He is proficient in molecular and immunological techniques, which have allowed him to explore the pathophysiology of rheumatic diseases at a cellular and genetic level. Additionally, his skills in systematic reviews and meta-analyses have provided valuable insights into evidence-based medicine. Dr. Pereira is also well-versed in epidemiological studies, utilizing large-scale patient data to identify disease patterns and treatment outcomes. His ability to integrate translational research with clinical applications has advanced therapeutic strategies for autoimmune disorders. Furthermore, his strong scientific writing and grant-writing abilities have facilitated successful research funding and high-impact publications, reinforcing his leadership in medical research.

Conclusion

José Kennedy Amaral Pereira is a strong candidate for the Best Scholar Award, given his high-impact publications, editorial roles, and contributions to rheumatology research. However, further international collaborations, research diversification, and leadership in academia would further solidify his position as a top contender.

Publications Top Noted

  • Chikungunya Fever and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Authors: José Kennedy Amaral, Robert Taylor Schoen, Michael E. Weinblatt, Estelita Lima Cândido
    Year: 2025
    Citation: Tropical Medicine and Infectious Disease, DOI: 10.3390/tropicalmed10020054

  • Bone erosions and joint damage caused by chikungunya virus: a systematic review
    Authors: José Kennedy Amaral, Peter Charles Taylor, Robert Taylor Schoen
    Year: 2024
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0433-2023

  • Chikungunya Arthritis Treatment with Methotrexate and Dexamethasone: A Randomized, Double-blind, Placebo-controlled Trial
    Authors: José Kennedy Amaral, Gabriela Lucena, Robert Taylor Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/0115733971278715231208114037

  • Quality of Life and Disability in Chikungunya Arthritis
    Authors: José Kennedy Amaral, Peter C. Taylor, Michael E. Weinblatt, Ícaro Bandeira, Robert T. Schoen
    Year: 2024
    Citation: Current Rheumatology Reviews, DOI: 10.2174/1573397119666230726113647

  • Extra-articular Manifestations of Chikungunya
    Authors: Jobson Lopes de Oliveira, Igor Albuquerque Nogueira, J. Kennedy Amaral, Luciana Ribeiro Campos, Mariana Macêdo Militão Mendonça, Marília de Brito Ricarte, Luciano Pamplona de Góes Cavalcanti, Robert T. Schoen
    Year: 2023
    Citation: Revista da Sociedade Brasileira de Medicina Tropical, DOI: 10.1590/0037-8682-0341-2023

  • Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis
    Authors: J. Kennedy Amaral, Clifton O. Bingham III, Peter C. Taylor, Luis M. Vilá, Michael E. Weinblatt, Robert T. Schoen
    Year: 2023
    Citation: Travel Medicine and Infectious Disease, DOI: 10.1016/j.tmaid.2022.102534

 

 

 

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346